Table of Content

Open Access iconOpen Access

ARTICLE

Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment

KIVANÇ ERGEN*, MUHAMMET BEKTAŞ**, SINA GÖKÇE**, RÜSTEM NURTEN**

* Kocaeli University Medical Faculty, Department of Biophysics, 41380 Umuttepe, Izmit-Kocaeli, TURKEY.
** Istanbul University Istanbul Faculty of Medicine, Department of Biophysics, 34390 Çapa-Ístanbul, TURKEY
Address correspondence to: Dr. Kivanç Ergen. Kocaeli University Medical Faculty, Department of Biophysics, 41380 Umuttepe, Ízmit-Kocaeli, TURKEY. Phone: (+90 262) 303 84 97. E-mail: kergen@hotmail.com

BIOCELL 2007, 31(1), 61-66. https://doi.org/10.32604/biocell.2007.31.061

Abstract

Eukaryotic elongation factor 2 (eEF-2) can undergo ADP-ribosylation in the absence of diphtheria toxin. The binding of free ADP-ribose and endogenous transferase-dependent ADP-ribosylation were distinct reactions for eEF-2, as indicated by different findings. Incubation of eEF-2 tryptic fragment 32/33 kDa (32F) with NAD was ADP-ribosylated and gave rise to the covalent binding of ADP-ribose to eEF-2. 32F was revealed to be at the C-terminal by Edman degradation sequence analysis.
In our study, the elution of 32F from SDS-PAGE was ADP-ribosylated both in the presence and absence of diphtheria toxin. These results suggest that endogenous ADP-ribosylation of 32F might be related to protein synthesis. This modification appears to be important for the cell function.

Keywords


Cite This Article

ERGEN, K., BEKTAŞ, M., GÖKÇE, S., NURTEN, R. (2007). Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment. BIOCELL, 31(1), 61–66.

Citations




cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1385

    View

  • 820

    Download

  • 0

    Like

Share Link